Search research articles
Contact Us
Filters
Showing results (131-140 of 177) with videos related to
Page
of 18
Sort By:
Transplantation and Cellular Therapy
|
March 15, 2022
Pathogen-Specific Humoral Immunity and Infections in B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Recipients with Multiple Myeloma
Srirama Josyula, Margot J Pont, Sayan Dasgupta, et al.
Blood
|
April 15, 2017
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
Rebecca A Gardner, Olivia Finney, Colleen Annesley, et al.
Journal for Immunotherapy of Cancer
|
February 7, 2024
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity
Tamer Basel Shabaneh, Andrew R Stevens, Sylvia M Stull, et al.
EMBO Molecular Medicine
|
September 7, 2022
Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activity
Gökhan Güner, Marlene Aßfalg, Kai Zhao, et al.
Blood
|
September 24, 2008
HapMap scanning of novel human minor histocompatibility antigens
Michi Kamei, Yasuhito Nannya, Hiroki Torikai, et al.
Haematologica
|
July 2, 2026
A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma
Valentín Ortiz-Maldonado, Emily C Liang, Jennifer J Huang, et al.
Blood
|
August 13, 2010
The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
Michael Hudecek, Thomas M Schmitt, Sivasubramanian Baskar, et al.
Blood
|
February 7, 2012
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
Brian G Till, Michael C Jensen, Jinjuan Wang, et al.
Nature Structural & Molecular Biology
|
March 24, 2020
Engineering and functionalization of large circular tandem repeat protein nanoparticles
Colin E Correnti, Jazmine P Hallinan, Lindsey A Doyle, et al.
Blood Advances
|
September 29, 2023
Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL
Emily C Liang, Aya Albittar, Jennifer J Huang, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 177) with videos related to
Sort By:
Page
of 18
Transplantation and Cellular Therapy
|
March 15, 2022
Pathogen-Specific Humoral Immunity and Infections in B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Recipients with Multiple Myeloma
Srirama Josyula, Margot J Pont, Sayan Dasgupta, et al.
Blood
|
April 15, 2017
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
Rebecca A Gardner, Olivia Finney, Colleen Annesley, et al.
Journal for Immunotherapy of Cancer
|
February 7, 2024
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity
Tamer Basel Shabaneh, Andrew R Stevens, Sylvia M Stull, et al.
EMBO Molecular Medicine
|
September 7, 2022
Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activity
Gökhan Güner, Marlene Aßfalg, Kai Zhao, et al.
Blood
|
September 24, 2008
HapMap scanning of novel human minor histocompatibility antigens
Michi Kamei, Yasuhito Nannya, Hiroki Torikai, et al.
Haematologica
|
July 2, 2026
A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma
Valentín Ortiz-Maldonado, Emily C Liang, Jennifer J Huang, et al.
Blood
|
August 13, 2010
The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
Michael Hudecek, Thomas M Schmitt, Sivasubramanian Baskar, et al.
Blood
|
February 7, 2012
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
Brian G Till, Michael C Jensen, Jinjuan Wang, et al.
Nature Structural & Molecular Biology
|
March 24, 2020
Engineering and functionalization of large circular tandem repeat protein nanoparticles
Colin E Correnti, Jazmine P Hallinan, Lindsey A Doyle, et al.
Blood Advances
|
September 29, 2023
Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL
Emily C Liang, Aya Albittar, Jennifer J Huang, et al.
Page
of 18